$1.7 Million Settlement – Medical Malpractice

Seeger Weiss Obtains $1.7 Million Recovery for Physician’s Failure to Diagnose Renal Disease in Timely Manner In a medical malpractice case pending in Supreme Court, Bronx County, Seeger Weiss came to a $1.7 million settlement agreement earlier this month on behalf of a client who has been diagnosed with end stage renal disease. The case, […]

August 9, 2010

Medical Malpractice

Seeger Weiss Obtains $1.7 Million Recovery for Physician’s Failure to Diagnose Renal Disease in Timely Manner

In a medical malpractice case pending in Supreme Court, Bronx County, Seeger Weiss came to a $1.7 million settlement agreement earlier this month on behalf of a client who has been diagnosed with end stage renal disease.

The case, brought against our client’s primary care physician, alleged that the physician’s failed to recognize signs and symptoms of kidney dysfunction over a period of nearly two years. In addition, this failure to diagnose and treat the client’s condition in its early stages was a significant factor in our client’s current diagnosis of advanced renal disease.

“This case underscores the importance of closely monitoring even routine blood test results,” said Seeger Weiss partner Marc S. Albert. “Simply put, this client’s kidney disease should have been diagnosed much earlier than it ultimately was. Unfortunately, blood tests over nearly a two year period, which showed elevated and continuously rising Creatinine and BUN levels—clear indications of renal disease—were not being carefully reviewed by his physician.”

During the course of the case, our client appeared on a CBS News special highlighting a problem that has become somewhat endemic in the medical field: physicians’ cavalier approach to reviewing patient’s test results. CBS, in a recent news story, reported on a number of patients—including our client—who had serious medical conditions slip through the cracks when test results were not carefully evaluated by their physician.

“We are extremely satisfied with what we feel is a just result for our client in this case,” said Mr. Albert.

Notwithstanding claims relating to this product, the drug/medical device remains approved by the U.S. FDA.

Related News

April 5, 2024
Lawdragon Names Four Seeger Weiss Partners to 500 Global Plaintiff Lawyers

Seeger Weiss is pleased to announce that Lawdragon has recognized four of the firm’s partners, including co-founders Chris Seeger and Stephen Weiss, as well as partners David Buchanan and Jennifer Scullion, on the 2024 Lawdragon 500 Global Plaintiff Lawyers. According to Lawdragon, this year’s honorees “stand tall as a global movement bringing justice across borders. […]

Read More
March 13, 2024
The Legal 500 recognizes Seeger Weiss as a Top Firm and Inducts Co-Founder Chris Seeger into the Hall of Fame

Seeger Weiss is pleased to announce that the firm was named one of The Legal 500 Top Product Liability, Mass Tort, and Class Action Firms. Co-founder Chris Seeger was also named to The Legal 500 Plaintiff Hall of Fame. These esteemed recognitions showcase Seeger Weiss’ and Chris Seeger’s unwavering dedication to ensuring corporate responsibility and […]

Read More
February 29, 2024
Seeger Weiss’ Founding Partner Chris Seeger and Senior Partner Dave Buchanan discussed the 3M settlement and other key wins with Law360

Seeger Weiss was recently recognized as Law360’s 2023 Product Liability Group of the Year, after the firm secured multiple litigation victories, including a groundbreaking $6 billion deal to settle the massive litigation brought by veterans and service members, who claimed that 3M’s combat earplugs caused harm to their hearing. Between 1999 and 2015, 3M knowingly […]

Read More